Our clinical data showed that AFP (>40 ng/ml) expression in all of HCC metastatic specimens from 100% (25/25) HCC patients, and 93.7% (15/16) AFP expression in non‐metastatic HCC patients. Here, AFP is linked to hepatocellular carcinoma.